[ORY-1001 inhibits glioblastoma cell growth by downregulating the Notch/HES1 pathway via suppressing lysine-specific demethylase 1 expression]. [PDF]
Yang H, Xiang Y, Tan T, Lei Y.
europepmc +1 more source
[Efficacy and safety of venetoclax combined with hypomethylating agents in the treatment of 83 patients with higher-risk myelodysplastic syndromes]. [PDF]
Liu L +6 more
europepmc +1 more source
Chronic inflammation, the tumor microenvironment and carcinogenesis [PDF]
Shuiping Tu +2 more
core
[Efficacy and safety analysis of venetoclax combined with hypomethylating agents for the treatment of higher-risk myelodysplastic syndromes in the real world]. [PDF]
Gao QY +8 more
europepmc +1 more source
[Preparation of magnetic bifunctional materials for exosome capture from serum and phosphopeptide enrichment]. [PDF]
Wang ZR, Zheng HJ, Jia Q.
europepmc +1 more source
[Determination of 30 homologues of phosphatidylcholines and lysophosphatidylcholines in human serum by liquid chromatography-tandem mass spectrometry and their correlation analysis with coronary artery disease]. [PDF]
Li WY +6 more
europepmc +1 more source
[Simultaneous determination of selinexor, posaconazole, venetoclax, and voriconazole in human plasma using ultra-high performance liquid chromatography-tandem mass spectrometry]. [PDF]
Xiao X, Li Y, Hu JF, Wan Q, Peng HW.
europepmc +1 more source
[Analysis of urine biomarkers in urothelial carcinoma based on untargeted metabolomics]. [PDF]
Liu S, Wang M, Wang W.
europepmc +1 more source
[Tripeptide polymer-based cell-imprinted hydrogels for high-efficiency circulating tumor cell capture]. [PDF]
Sun W, Zhang Z, Zhao X, Chen J, Qing G.
europepmc +1 more source
[Research progress in the application of molecular imprinting technology in catalysis]. [PDF]
Ye WM +5 more
europepmc +1 more source

